bioRxiv is receiving many new papers on coronavirus SARS-CoV-2.   A reminder: these are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information.

COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

10032 Articles (7892 medRxiv, 2140 bioRxiv)

Most recent first Previous |  Page 7: Articles 61-70  | Next

Inconsistent with the intent of public health strategies on incidence and fatality in states with extra mandatory stay-at-home and face masks orders during COVID-19 pandemic in the US
Wu, X., Wu, S. X.
10.1101/2020.10.25.20219279 — Posted: 2020-10-27
Who is (Not) Complying with the Social Distancing Directive and Why? Testing a General Framework of Compliance with Multiple Measures of Social Distancing
Fazio, R. H., Ruisch, B. C., Moore, C. A., Granados Samayoa, J. A., Boggs, S. T., Ladanyi, J. T.
10.1101/2020.10.26.20219634 — Posted: 2020-10-27
Impact of the COVID-19 pandemic on remote mental healthcare and prescribing in psychiatry
Patel, R., Irving, J., Brinn, A., Broadbent, M., Shetty, H., Pritchard, M., Downs, J., Stewart, R., Harland, R., McGuire, P.
10.1101/2020.10.26.20219576 — Posted: 2020-10-27
Long-term monitoring of SARS-CoV-2 in wastewater of the Frankfurt metropolitan area in Southern Germany
Agrawal, S., Orschler, L., Lackner, S.
10.1101/2020.10.26.20215020 — Posted: 2020-10-27
Detecting COVID-19 infection hotspots in England using large-scale self-reported data from a mobile application
Varsavsky, T., Graham, M. S., Canas, L. S., Ganesh, S., Capdevila Puyol, J., Sudre, C. H., Murray, B., Modat, M., Cardoso, M. J., Astley, C. M., Drew, D. A., Nguyen, L. H., Fall, T., Gomez, M. F., Franks, P. W., Chan, A. T., Davies, R., Wolf, J., Steves, C. J., Spector, T. D., Ourselin, S.
10.1101/2020.10.26.20219659 — Posted: 2020-10-27
Impact of COVID-19 on the diagnoses, HbA1c monitoring and mortality in people with type 2 diabetes: a UK-wide cohort study involving 13 million people in primary care
Carr, M. J., Wright, A. K., Leelarathna, L., Thabit, H., Milne, N., Kanumilli, N., Ashcroft, D. M., Rutter, M. K.
10.1101/2020.10.25.20200675 — Posted: 2020-10-27
Saliva is a promising alternative specimen for the detection of SARS-CoV-2 in children and adults
Yee, R., Truong, T. T., Pannaraj, P. S., Eubanks, N., Gai, E., Jumarang, J., Turner, L., Peralta, A., Lee, Y., Dien Bard, J. T.
10.1101/2020.10.25.20219055 — Posted: 2020-10-27
High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris
Anna, F., Goyard, S., Lalanne, A. I., Nevo, F., Gransagne, M., Souque, P., Louis, D., Gillon, V., Turbiez, I., Bidard, F.-C., Gobillon, A., Savignoni, A., Guillot-Delost, M., Dejardin, F., Dufour, E., Petres, S., Richard-Le Goff, O., Choucha, Z., Helynck, O., Janin, Y. L., Escriou, N., Charneau, P., ROSE, T., Lantz, O.
10.1101/2020.10.25.20219030 — Posted: 2020-10-27
Community prevalence of SARS-CoV-2 in England during April to September 2020: Results from the ONS Coronavirus Infection Survey
Pouwels, K. B., House, T., Pritchard, E., Robotham, J. V., Birrell, P., Gelman, A., Vihta, K.-D., Bowers, N., Boreham, I., Thomas, H., Lewis, J., Bell, I., Bell, J. I., Newton, J. N., Farrar, J., Diamond, I., Benton, P., Walker, A. S.
10.1101/2020.10.26.20219428 — Posted: 2020-10-27
Features of C-reactive protein in COVID-19 patients within various period: a cohort study
Huang, G., Qu, G., Yu, H., Zhang, M., Song, X., Chen, L., Zhu, H., Wang, Y., Pei, B.
10.1101/2020.10.26.20219360 — Posted: 2020-10-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).